UNSPSC 51385502: Salacetamide

This classification denotes a nonsteroidal antiinflammatory drug with the molecular formula C9H9NO3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 7G29CRR596, chemically known as salicylamide, n-acetyl- but generally known as salacetamide, which bears US NIH Compound Identifier 10252. European Medicines Agency schedules Salacetamide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10415MIG. The term SALACETAMIDE is an International Non-Proprietary Name.

UNSPSC 51385502 Salacetamide is a Commodity code that in recent state and local procurement activity denotes pharmaceuticals and related health-care products—though the three recent opportunities on file show misalignment with the specific drug named in the code. Seminole County, Florida is procuring naloxone and drug deactivation systems through an IFB issued June 30, 2026, with a response deadline of July 26, 2023 (delivered quarterly in quantities of 1,900 units of naloxone and 800 deactivation systems annually), while the Texas Health and Human Services Commission posted a Request for Information on April 3, 2026, to explore direct-to-manufacturer prescription fulfillment models for its Therapeutic Pharmacy Initiative. The Minnesota Multistate Cooperative Purchasing Alliance issued an RFP on January 20, 2026, for generic multi-source pharmaceuticals and over-the-counter products distributed through three authorized wholesalers (AmerisourceBergen/Cencora, Cardinal Health, and Morris & Dickson), with proposals due March 26, 2026, and contract start July 1, 2026. State and local issuing bodies under this code span county health departments, state pharmacy benefit programs, and multi-state cooperative purchasing vehicles; the MMCAP procurement explicitly includes participating state and local government facilities across multiple jurisdictions.

Recent activity concentrates in Florida, Texas, and Minnesota. The Seminole County IFB specifies quarterly delivery to the Seminole County Community Health Building in Sanford, with vendors responsible for all shipping costs and required to hold drug-free workplace certification, E-Verify compliance, and specified insurance coverage including workers' compensation and general liability. The MMCAP RFP requires cGMP and Drug Supply Chain Security Act compliance, pricing submitted through authorized wholesalers with chargeback systems, and commercial general liability of $5,000,000 per occurrence; the contract term runs two years with optional extensions, while award values and budget ranges are not disclosed in any of the three solicitations. No explicit set-aside designations for disadvantaged enterprises appear in the available documentation across the three opportunities.